RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
144 hedge funds and large institutions have $1.94B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% more funds holding
Funds holding: 116 → 144 (+28)
6% less call options, than puts
Call options by funds: $38.7M | Put options by funds: $41.4M
Holders
144
Holding in Top 10
10
Calls
$38.7M
Puts
$41.4M
Top Buyers
| 1 | +$68.7M | |
| 2 | +$65M | |
| 3 | +$46.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.4M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$18.9M |
Top Sellers
| 1 | -$53.9M | |
| 2 | -$45.6M | |
| 3 | -$33.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$18.3M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$14.6M |